Firstly, ACTR2 overexpression greatly elevated the protein level of β-catenin, c-Myc, and cyclin D1 in DLBCL cells, but the introduction of XAV939 suppressed the elevation (Figure 5(a)). The gene discussed is ACTR2; the disease is diffuse large B-cell lymphoma.